Data / Form D filings / Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc.: Form D filings
Timber Pharmaceuticals, Inc., a pharmaceuticals company in Basking Ridge, NJ, filed 8 Form D notices with the SEC between 2014 and 2022. The latest, on October 11, 2022, reports an offering of no set size with nothing sold yet to 2 investors.
Find out what Timber Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 110 ALLEN ROAD, SUITE 401, Basking Ridge, NJ, 07920
- Phone
- (908) 636-7160
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1504167
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 11, 2022 | New notice | Indefinite | $0 | Indefinite | 2 | Oct 3, 2022 | sec.gov |
| Oct 7, 2016 | New notice | $930,000 | $930,000 | $0 | 5 | Sep 25, 2016 | sec.gov |
| Mar 19, 2015 | New notice | $508,468 | $508,468 | $0 | 1 | Jan 3, 2014 | sec.gov |
| Mar 19, 2015 | New notice | $134,332 | $134,332 | $0 | 16 | Sep 3, 2014 | sec.gov |
| Mar 19, 2015 | Amendment | $18,621,799 | $7,869,775 | $10,752,024 | 51 | Apr 11, 2014 | sec.gov |
| Mar 18, 2015 | New notice | $1,750,000 | $1,750,000 | $0 | 25 | Aug 19, 2012 | sec.gov |
| Apr 18, 2014 | New notice | $6,000,000 | $1,500,000 | $4,500,000 | 2 | Apr 11, 2014 | sec.gov |
| Jan 31, 2014 | New notice | $7,025 | $7,025 | $0 | 4 | Jan 23, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Lucchese | Executive Officer | |
| Alan M. Mendelsohn | Executive Officer | |
| Edward J. Sitar | Director | |
| David E. Cohen | Director | |
| Lubor M. Gaal | Director | |
| John Koconis | Executive Officer, Director | |
| Gianluca M. Pirozzi | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Oct 10, 2022 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Timber Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.